港股消費股集體走強 上海海關驗放全國首批進口輝瑞新冠治療藥
格隆匯3月18日丨港股餐飲、零售、濠賭等消費股集體走強。永利澳門和澳博控股漲超8%,莎莎國際漲超7%,呷哺呷哺、九毛九、太興集團漲超5%,美高梅、金沙中國漲超4%。消息面上,據上海海關,3月17日22時30分,2.12萬盒進口新冠病毒治療藥物“奈瑪特韋/利托那韋片”(Paxlovid),經上海外高橋保税區海關驗放後,辦結全部進口通關手續,火速運往全國抗疫一線。據瞭解,這是該種藥物被納入最新版新冠肺炎診療方案後全國的首批進口。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.